Clinical Updates

Swiss drugmaker Roche said on Monday the European Commission had approved a new formulation of its breast cancer drug Herceptin… »   

The U.S. Food and Drug Administration said it was investigating a case of a rare and serious brain infection that… »   

Acura Pharmaceuticals Inc said a painkiller made with its abuse-deterrent technology did not show statistically significant results in reducing… »   

Generic drugmaker Akorn Inc will buy rival Hi-Tech Pharmacal Co Inc for $640 million to expand its eye drug portfolio… »   

Positive results for Roche’s experimental eye drug should bolster its position in the multibillion-dollar-a-year market for vision loss treatments, as… »   

Rigel Pharmaceuticals Inc said it will stop developing its experimental asthma drug after the therapy failed in a mid-stage trial,… »   

Imagine a weight-loss drug that not only helps you shed a few pounds, but does so without asking you to… »   

Bayer’s cancer drug Nexavar was given priority review status by U.S. healthcare regulators for the oral drug’s use against a… »   

Fewer older children and adults were hospitalized for severe diarrhea once the U.S. started vaccinating babies against rotavirus in 2006,… »   

The Michigan state Senate on Tuesday voted 20-18 to approve a bill to expand Medicaid, the health program for the… »   

India has partly revoked patents granted to a Roche Holding AG breast cancer medicine, the Swiss firm said on Sunday,… »   

Isis Pharmaceuticals Inc said it will stop developing its experimental rheumatoid arthritis (RA) drug after a mid-stage trial showed the… »   

Oral ketoconazole (Nizoral) should never be used as first-line therapy for any type of fungal infection because of the risk… »   

A new regulatory pathway could shave years off the traditional drug approval process in the United States, according to some… »   

Canadian biopharmaceutical company Transition Therapeutics said it acquired development and marketing rights for Eli Lilly’s experimental drug for arthritis pain.